GlassScriptPhysician profile
Paul J Schwartz
NPI 1083888770
$9,196.10
in general payments reported to CMS, 2019-2025
7 companies · $617 in 2025
The $617 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,566 · 2020: $2,000 · 2021: $177 · 2022: $389 · 2023: $320 · 2024: $127 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796 · Travel and Lodging: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.35 |
| Travel and Lodging | $267.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $8,112.79 | 2019-2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Depuy Synthes Sales INC. | $327.34 | 2019-2024 | Viper, Spine & Trauma 3d Navigation |
| Si-Bone, INC. | $287.04 | 2023 | |
| Royal Biologics, INC. | $174.43 | 2025 | |
| Kerecis Limited | $149.94 | 2022 | |
| Corelink, LLC | $100.00 | 2022 | |
| Medtronic, INC. | $44.56 | 2025 | Fusion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.